Crystal Jin

CEO at Bound Therapeutics

Speaker

Dr. Jin is Co-Founder and CEO of Bound Therapeutics, a biotechnology company developing AI-driven RNA therapeutics with targeted delivery for treatment-resistant diseases. With more than 15 years of experience in RNA biology, drug delivery, and therapeutic development, she leads Bound’s efforts to advance RNA-targeted medicines in oncology and beyond.

Dr. Jin earned her PhD in Molecular Pharmacology and Structural Biology from Thomas Jefferson University. At Bound, she leads development of a first-in-class miR-21 inhibitor, and the Magic Bullet Designer™ AI/ML platform for discovering cell and tissue-specific delivery peptides. Her work aims to enable precise, programmable RNA medicines for cancer, neurodegeneration, and other chronic diseases.